Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.790
+0.140 (3.01%)
At close: Mar 9, 2026, 4:00 PM EDT
4.800
+0.010 (0.21%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Anavex Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Cash & Equivalents | 131.75 | 102.58 | 132.19 | 151.02 | 149.16 | 152.11 | |
| Cash & Short-Term Investments | 131.75 | 102.58 | 132.19 | 151.02 | 149.16 | 152.11 | |
| Cash Growth | 9.09% | -22.40% | -12.47% | 1.25% | -1.94% | 420.04% | |
| Other Receivables | 0.84 | 0.81 | 2.45 | 2.71 | 3.19 | 9.14 | |
| Receivables | 0.84 | 0.81 | 2.45 | 2.71 | 3.19 | 9.14 | |
| Prepaid Expenses | 0.4 | 0.43 | 0.93 | 0.65 | 0.35 | 0.37 | |
| Total Current Assets | 132.99 | 103.82 | 135.57 | 154.39 | 152.71 | 161.62 | |
| Accounts Payable | 2.64 | 4.25 | 9.63 | 4.32 | 3.83 | 4.74 | |
| Accrued Expenses | 2.93 | 3.89 | 4.84 | 7.3 | 5.95 | 5.61 | |
| Current Unearned Revenue | 0.81 | 0.81 | 0.84 | 0.92 | 0.44 | 0.44 | |
| Total Current Liabilities | 6.37 | 8.95 | 15.3 | 12.53 | 10.21 | 10.8 | |
| Common Stock | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | |
| Additional Paid-In Capital | 514.65 | 477.23 | 456.25 | 434.84 | 387.98 | 348.33 | |
| Retained Earnings | -388.13 | -382.45 | -336.07 | -293.07 | -245.56 | -197.59 | |
| Total Liabilities & Equity | 132.99 | 103.82 | 135.57 | 154.39 | 152.71 | 161.62 | |
| Net Cash (Debt) | 131.75 | 102.58 | 132.19 | 151.02 | 149.16 | 152.11 | |
| Net Cash Growth | 9.09% | -22.40% | -12.47% | 1.25% | -1.94% | 420.04% | |
| Net Cash Per Share | 1.53 | 1.20 | 1.58 | 1.89 | 1.94 | 2.18 | |
| Filing Date Shares Outstanding | 92.67 | 89.35 | 84.82 | 82.09 | 77.96 | 76.02 | |
| Total Common Shares Outstanding | 92.67 | 86.67 | 84.8 | 82.07 | 77.94 | 75.92 | |
| Working Capital | 126.62 | 94.87 | 120.26 | 141.85 | 142.49 | 150.82 | |
| Book Value Per Share | 1.37 | 1.09 | 1.42 | 1.73 | 1.83 | 1.99 | |
| Tangible Book Value | 126.62 | 94.87 | 120.26 | 141.85 | 142.49 | 150.82 | |
| Tangible Book Value Per Share | 1.37 | 1.09 | 1.42 | 1.73 | 1.83 | 1.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.